These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 3099030

  • 1. [Ultrastructural study of rat mammary tumors and human breast cancer cells following treatment with tamoxifen].
    Kamioki S.
    Gan No Rinsho; 1986 Nov; 32(14):1809-18. PubMed ID: 3099030
    [Abstract] [Full Text] [Related]

  • 2. [Changes of hormone receptor status in various treatment for human breast cancer and DMBA tumor of the rat].
    Iino Y, Yamazaki K, Ishikawa H, Endo K, Arai T, Ogawa T, Hoshino K, Ishida T, Yokoe T, Takahashi T.
    Gan No Rinsho; 1984 Oct; 30(13):1633-7. PubMed ID: 6239934
    [Abstract] [Full Text] [Related]

  • 3. Similarities and differences in the ultrastructure of two hormone-dependent and one independent human breast carcinoma grown in athymic nude mice: comparison with the rat DMBA-induced tumor and normal secretory mammocytes.
    Anderson WA, Perotti ME, McManaway M, Lindsey S, Eckberg WR.
    J Submicrosc Cytol; 1984 Oct; 16(4):673-90. PubMed ID: 6438351
    [Abstract] [Full Text] [Related]

  • 4. Tamoxifen-induced fluorescence as a marker of human breast tumor cell responsiveness to hormonal manipulations: correlation with progesterone receptor content and ultrastructural alterations.
    Mouriquand J, Jacrot M, Louis J, Mermet MA, Saez S, Sage JC, Mouriquand C.
    Cancer Res; 1983 Aug; 43(8):3948-54. PubMed ID: 6861157
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Effect of tamoxifen plus octreotide on DMBA-induced mammary tumors in rats].
    Zeng XZ, Yao ZX.
    Zhonghua Yi Xue Za Zhi; 2005 Jan 05; 85(1):28-32. PubMed ID: 15808071
    [Abstract] [Full Text] [Related]

  • 10. Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.
    Rydén L, Jirström K, Bendahl PO, Fernö M, Nordenskjöld B, Stål O, Thorstenson S, Jönsson PE, Landberg G.
    J Clin Oncol; 2005 Jul 20; 23(21):4695-704. PubMed ID: 16034044
    [Abstract] [Full Text] [Related]

  • 11. [Experimental and clinical study on endocrine therapy of breast carcinoma, with special reference to the nuclear estrogen receptor].
    Kubouchi K.
    Nihon Geka Gakkai Zasshi; 1984 Nov 20; 85(11):1405-17. PubMed ID: 6521721
    [Abstract] [Full Text] [Related]

  • 12. Endocrine therapy for advanced carcinoma of the breast: relationship between the effect of tamoxifen upon concentrations of progesterone receptor and subsequent response to treatment.
    Howell A, Harland RN, Barnes DM, Baildam AD, Wilkinson MJ, Hayward E, Swindell R, Sellwood RA.
    Cancer Res; 1987 Jan 01; 47(1):300-4. PubMed ID: 3791215
    [Abstract] [Full Text] [Related]

  • 13. Chemoendocrine therapy in DMBA-induced rat mammary carcinoma.
    Morimoto T, Yamamoto H, Komaki K, Konishi N, Tanaka T, Yamakawa T, Mori T, Sasa M, Monden Y.
    Tokushima J Exp Med; 1990 Dec 01; 37(3-4):59-68. PubMed ID: 2128782
    [Abstract] [Full Text] [Related]

  • 14. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
    Arpino G, Weiss H, Lee AV, Schiff R, De Placido S, Osborne CK, Elledge RM.
    J Natl Cancer Inst; 2005 Sep 07; 97(17):1254-61. PubMed ID: 16145046
    [Abstract] [Full Text] [Related]

  • 15. How ADAM-9 and ADAM-11 differentially from estrogen receptor predict response to tamoxifen treatment in patients with recurrent breast cancer: a retrospective study.
    Sieuwerts AM, Meijer-van Gelder ME, Timmermans M, Trapman AM, Garcia RR, Arnold M, Goedheer AJ, Portengen H, Klijn JG, Foekens JA.
    Clin Cancer Res; 2005 Oct 15; 11(20):7311-21. PubMed ID: 16243802
    [Abstract] [Full Text] [Related]

  • 16. Independent regulation of growth and steroid receptors in uterus and mammary tumors of rats.
    Janssens JP, Billiet G, Bonte J, De Loecker W.
    Anticancer Res; 1983 Oct 15; 3(6):385-91. PubMed ID: 6230984
    [Abstract] [Full Text] [Related]

  • 17. Steroid hormone receptors in mammary carcinoma: the effect of tamoxifen.
    Koenders AJ, Beex LV, Geurts-Moespot J, Benraad TJ.
    Eur J Cancer (1965); 1980 Oct 15; Suppl 1():63-6. PubMed ID: 7318871
    [No Abstract] [Full Text] [Related]

  • 18. [Measurement of estrogen receptor in relation to the prediction of hormone dependency in 7,12-dimethylbenz(a)anthracene-induced rat breast cancer and in human breast cancer (author's transl)].
    Abe Y.
    Fukuoka Igaku Zasshi; 1978 Sep 15; 69(9):400-13. PubMed ID: 102576
    [No Abstract] [Full Text] [Related]

  • 19. Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer.
    Berns EM, Foekens JA, Vossen R, Look MP, Devilee P, Henzen-Logmans SC, van Staveren IL, van Putten WL, Inganäs M, Meijer-van Gelder ME, Cornelisse C, Claassen CJ, Portengen H, Bakker B, Klijn JG.
    Cancer Res; 2000 Apr 15; 60(8):2155-62. PubMed ID: 10786679
    [Abstract] [Full Text] [Related]

  • 20. [Effects of chemo-endocrine therapy on DMBA-induced rat mammary carcinoma].
    Yamamoto H, Morimoto T, Monden A.
    Nihon Geka Gakkai Zasshi; 1989 Oct 15; 90(10):1786-92. PubMed ID: 2512479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.